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The  lungs  of Cystic  ﬁbrosis  (CF)  patients  are  often  colonized  and/or  infected  by  Staphylococcus  aureus  for
years, mostly  by  one  predominant  clone.  For  long-term  survival  in this  environment,  S.  aureus  needs  to
adapt  during  its interactions  with  host  factors,  antibiotics,  and other  pathogens.  Here,  we  study  long-term
transcriptional  as well  as  genomic  adaptations  of an  isogenic  pair  of  S. aureus  isolates  from  a single  patient
using  RNA  sequencing  (RNA-Seq)  and whole  genome  sequencing  (WGS).  Mimicking  in  vivo conditions,
we  cultivated  the S. aureus  isolates  using  artiﬁcial  sputum  medium  before  harvesting  RNA  for  subse-
quent  analysis.  We  conﬁrmed  our RNA-Seq  data  using  quantitative  real-time  (qRT)-PCR  and  additionally
investigated  intermediate  isolates  from  the  same  patient  representing  in total  13.2  years  of  persistence
in  the  CF airways.  Comparative  RNA-Seq  analysis  of  the  ﬁrst and  the  last  (“late”)  isolate  revealed  sig-
niﬁcant  differences  in  the late  isolate  after  13.2  years  of persistence.  Of the  2545  genes  expressed  in
both  isolates  that  were  cultivated  aerobically,  256  genes  were  up-  and  161  were  down-regulated  with  a
minimum  2-fold  change  (2f).  Focusing  on  25  highly  (≥8f)  up-  (n = 9) or  down-  (n  = 16) regulated  genes,
we  identiﬁed  several  genes  encoding  for  virulence  factors  involved  in  immune  evasion,  bacterial  spread
or secretion  (e.g.  spa,  sak,  and  esxA).  Moreover,  these  genes  displayed  similar  expression  trends  under
aerobic,  microaerophilic  and anaerobic  conditions.  Further  qRT-PCR-experiments  of  highly  up- or  down-
regulated  genes  within  intermediate  S. aureus  isolates  resulted  in  different  gene  expression  patterns
over  the  years.  Using  sequencing  analysis  of the  differently  expressed  genes  and  their  upstream  regions
in  the late S. aureus  isolate  resulted  in only  few  genomic  alterations.  Comparative  transcriptomic  anal-
ysis revealed  adaptive  changes  affecting  mainly  genes  involved  in  host-pathogen  interaction.  Although
the  underlying  mechanisms  were not  known,  our results  suggest  adaptive  processes  beyond  genomic
mutations  triggered  by  local  factors  rather  than  by activation  of global  regulators.
©  2014  The  Authors.  Published  by  Elsevier  GmbH.  This  is  an  open  access  article  under  the  CCntroduction
Cystic ﬁbrosis (CF) is the most common autosomal reces-
ive genetic disorder in the Caucasian population (O’Sullivan and
reedman, 2009). The malfunction of the CF transmembrane con-
uctance regulator (CFTR), a chloride channel of the epithelial cells
n the lung and digestive system in particular, results in thickening
f mucus and digestive ﬂuids thereby leading to a strongly impaired
ucociliary clearance in the lung (Fahy and Dickey, 2010). As a
esult, CF patients suffer from chronic airway inﬂammation and
∗ Corresponding author. Tel.: +49 251 8352316; fax: +49 251 8355688.
E-mail address: mellmann@uni-muenster.de (A. Mellmann).
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438-4221/© 2014 The Authors. Published by Elsevier GmbH. This is an open access artic
http://creativecommons.org/licenses/by-nc-nd/3.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
recurrent bacterial infections resulting in progressive pulmonary
insufﬁciency (Konstan et al., 2009). Staphylococcus aureus is the
most prevalent respiratory pathogen in CF children and adolescents
and is one of the ﬁrst pathogens that can be isolated from CF air-
ways (Cystic Fibrosis Foundation Patient Registry, 2011; Kahl, 2010;
Viviani et al., 2012). In adult CF patients, Pseudomonas aeruginosa is
more common and often replaces S. aureus,  though the prevalence
of S. aureus in adults still remains at about 40–60% (Cystic Fibrosis
Foundation Patient Registry, 2011; Kahl, 2010). The same clone of S.
aureus persists in many patients for months or even years (Branger
et al., 1996; Kahl et al., 2003b; Renders et al., 1997).
While the natural habitat of S. aureus are the anterior nares
in the healthy human population (Nouwen et al., 2004), the thick
and sticky mucus in the lungs of CF patients presents a new niche.
le under the CC BY-NC-ND license
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oreover, CF airway disease is characterized by the abundance of
olymorphonuclear neutrophils (Cohen and Prince, 2012) and by
he frequent presence of co-colonizing species such as P. aeruginosa
r Haemophilus inﬂuenza, which compete with S. aureus for nutri-
nts. In addition, bacterial pulmonary infections are frequently
reated with antibiotics and various ecological niches (e.g. aerated
nd non-aerated areas) occur in the CF lung environment (Schobert
nd Tielen, 2010; Tunney et al., 2008; Worlitzsch et al., 2002) that
irect the selection of differently adapted variants, as shown for
. aeruginosa (Hoboth et al., 2009; Hogardt et al., 2007). Therefore,
o survive in this hostile niche S. aureus has to adapt to changing
elective pressures during long-term persistence. Some adaptive
echanisms have been discovered which account for the diversity
bserved in the CF S. aureus population, such as phage insertions
nd excisions (Goerke et al., 2004), changes in the protein A gene
epeat region (Kahl et al., 2005) and emergence of small-colony
ariants (SCVs) (Besier et al., 2007; Kahl et al., 1998; Wolter et al.,
013). The SCVs exhibit a smaller colony size, less pigmentation
nd less hemolysis on Columbia blood agar plates compared to
ild-type S. aureus strains and are thought to be associated with
ong-term adaptation to the CF airways (Kahl, 2013; Kahl et al.,
003a,b; Proctor et al., 2006) showing increased antibiotic resis-
ance and the ability to persist intracellularly, thereby protected
rom the host immune system and antibiotics (Besier et al., 2007;
ahl et al., 1998, 2000).
Whole-genome sequencing has been used to study the adapta-
ion of S. aureus to the human host in sequential isolates. Mwangi
t al. (2007) detected a stepwise adaptation of S. aureus to the host
uring prolonged acute infection leading to vancomycin resistance,
ielding 35 single nucleotide polymorphisms (SNP) in 31 loci in
he ﬁnal of several sequential isolates in three months. Gao et al.
2010) analyzed two methicillin-resistant S. aureus isolates, a nor-
al  and a SCV phenotype, recovered from a patient 3.8 months
part. Using whole-genome sequencing and microarray transcrip-
ional analysis, the authors discovered two novel point mutations
n key staphylococcal genes and global transcriptional changes in
he SCV strain promoting persistent S. aureus infection (Gao et al.,
010). McAdam et al. (2011) sequenced three sequential S. aureus
solates, which were obtained from the sputum of one individual
F patient after 11 and 26 months. The authors identiﬁed variation
n phage content, genetic polymorphisms in genes associated with
ntibiotic resistance (e.g. fusA) and global regulation of virulence
e.g. codY, sigB) (McAdam et al., 2011).
Whereas genomic and phenotypic changes have been investi-
ated, the transcriptional changes as part of long-term adaptive
rocesses of S. aureus in the CF lung are not yet well understood. To
et deeper insights into the changes of transcription of genes, we
mployed next-generation RNA-Sequencing (RNA-Seq) on rRNA-
epleted total RNA as screening method and quantitative realtime
CR (qRT-PCR) for conﬁrmation of transcriptional changes of an
sogenic pair of sequential S. aureus isolates recovered from the
irways of an individual CF patient 13.2 years apart. From the same
air of isolates, we determined the complete genome sequence,
hich served not only as optimal reference sequence for RNA-
eq data analysis but also helped to elucidate potential genomic
hanges in differentially regulated genes. To mimic  the CF lung
abitat, we cultivated the S. aureus isolates in an artiﬁcial sputum
edium (ASM) (Sriramulu et al., 2005). Based on our RNA-Seq data,
e selected a number of genes, which were highly differentially
xpressed in the last (“late”) S. aureus isolate and conﬁrmed trans-
riptional changes by qRT-PCR. Furthermore, using ﬁve additional
ntermittent sequential S. aureus isolates recovered from the same
atient, we examined some of these genes by qRT-PCR to detect
peciﬁc expression patterns over the course of time. To determine
he inﬂuence of variable oxygen saturations on the gene expres-
ion, we selected interesting candidate genes that were differentlyedical Microbiology 305 (2015) 38–46 39
expressed in the late isolate under aerobic conditions, and tested
their expression in both isolates under microaerophilic and anaer-
obic conditions.
Materials and methods
Bacteria, culture conditions and RNA preparation
Seven sequential isogenic S. aureus isolates, which were recov-
ered from the airways of a male CF patient (born in 1993) from 1995
to 2008 (patient 20 in Hirschhausen et al. (2013)), were selected
for further analysis (Supplementary data: Table S1). The early and
intermediate S. aureus isolates were isolated from the upper air-
ways (throat or nasal swabs) and the late isolate from a sputum
sample of the lower airways. Co-colonization or infection with P.
aeruginosa was not detected in the patient during the study period.
All isolates were penicillin resistant, but methicillin sensitive and
exhibited a normal phenotype regarding colony size. All isolates
belonged to the MLST sequence type (ST) 30 and spa type t012 or
the related spa type t021 (deletion of a single repeat changed the
spa type t012 to t021) and shared an identical PFGE pattern (Sup-
plementary data: Table S1). All isolates were stored at −80 ◦C until
analysis and freshly cultured for all experiments.
The S. aureus isolates were cultivated in ASM (Sriramulu
et al., 2005) containing 25 mg/ml  albumin (Serva Electrophoresis
GmbH, Heidelberg, Germany), 5 mg/ml  mucin from porcine stom-
ach (Sigma, Sigma-Aldrich Chemie GmbH, München, Germany),
2.7 mg/ml  DNA from ﬁsh sperm (Serva), 0.8 mg/ml  glucose,
0.25 mg/ml  amino acids (Sigma), 69 mM NaCl, 3 mM CaCl2, 20 mM
HEPES (Sigma), 0.5 mM urea, 1.0% FBS (Fiebrig Nährstofftech-
nik, Idstein-Niederauroff, Germany), and 0.5% egg yolk emulsion
(Sigma), pH 6.9. Before RNA extraction, we performed growth
curve experiments to determine the time point of the logarithmic
growth phase for RNA extraction. Due to the speciﬁc character-
istics of the ASM medium to mimic  the in vivo conditions, we
observed a time span between 4 and 16 h as logarithmic growth
phase (data not shown). The isolates were grown aerobically,
microaerophilic (AnaerocultA, Merck GmbH, Darmstadt, Germany)
or anaerobic (AnaerocultC, Merck) at 37 ◦C and 100 rpm, after dilu-
tion of an overnight culture to a starting optical density of 0.1.
After 6 h of growth, total RNA was  puriﬁed harvesting the bacte-
ria and twice the volume of the culture volume of RNAprotect
Bacteria Reagent (Qiagen GmbH, Hilden, Germany) was  used for
in vivo stabilization of total RNA. Subsequently, total RNA was
extracted with the RNeasy Kit (Qiagen) using the bacterial lysis
protocol recommended by the manufacturer in combination with a
mechanical disruption of bacteria via glass beads (≤106 m diam-
eter, Sigma). Speciﬁcally, for cell lysis the bacteria were incubated
in TE (10 mM TrisCl, 1 mM EDTA, pH 7.0) containing 83 g/ml
lysostaphin (Sigma) and 33 mg/ml  Proteinase K (Carl Roth GmbH,
Karlsruhe, Germany) for 40 min at 37 ◦C. In addition, to yield higher
amounts of total RNA and reduce genomic DNA contaminations,
gDNA eliminator spin columns and RLT plus puffer (Qiagen) were
used during the RNA extraction protocol. Moreover, total RNA was
DNase I digested twice (RNase-Free DNase I, Qiagen, 2× or 4× ﬁnal
concentration, as recommended by the manufacturer) in reaction
volumes of 50 or 100 l, incubated for 20 minutes at room temper-
ature and cleaned up by the RNA clean up protocol. Total RNA was
checked for DNA contamination via PCR and further quality con-
trolled using the Agilent 2100 bioanalyzer according to the Agilent
RNA 6000 nano protocol (Agilent Technologies, Inc., Santa Clara, CA,
USA). Only RNA samples of high quality (RIN value ≥8.0) were used
for cDNA library construction and/or reverse transcription prior
to qRT-PCR. Total RNA was  stored at −20 ◦C. During RNA prepara-
tion, RNA samples (technical replicates) were pooled before DNase
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(no-template control) was  used for qRT-PCR reactions (in dupli-
cates) in a total volume of 15 l containing both primers in a ﬁnal0 N. Windmüller et al. / International Journ
 digestion. RNA-Seq and qRT-PCR experiments were carried out on
ifferent RNA samples (technical replicates) to ensure an indepen-
ent data analysis for each approach.
hole genome sequencing of the early and late S. aureus isolate
nd de novo assembly
For whole genome shotgun sequencing of the early (F343795)
nd the late (CF74808) S. aureus isolate, sequencing libraries were
repared using the Nextera XT chemistry (Illumina) for a 100 bp
aired-end sequencing run on an Illumina HiScanSQ sequencer
n accordance to the manufactures’ recommendations (Illumina).
o achieve a single chromosomal sequence (one contig) WGS
as additionally performed on a PacBio RSII (Paciﬁc Biosciences,
enlo Park, CA, USA). Therefore, SMRTbellTM template libraries
ere prepared according to the manufactures’ instructions (Paciﬁc
iosciences), following the Procedure & Checklist for 10 kb Tem-
late Preparation and Sequencing. Brieﬂy, for preparation of 10 kb
ibraries ∼5 g genomic DNA was end-repaired and ligated to
airpin adapters applying components from the DNA/Polymerase
inding Kit 2.0. Reactions were carried out according to the man-
facturer’s instructions. SMRTbellTM templates were Exonuclease
reated for removal of incompletely formed reaction products.
onditions for annealing of sequencing primers and binding of
olymerase to puriﬁed SMRTbellTM templates were assessed with
he Calculator in RS Remote (Paciﬁc Biosciences). SMRT sequencing
as carried out taking one 180-min movie for each SMRT cell. In
otal ﬁve SMRT cells were run for the early and four SMRT cells for
he late isolate. De novo genome assemblies for both strains were
erformed using the “RS HGAP Assembly.2” protocol included in
MRTPortal version 2.1.1 using standard parameters. Afterwards,
nsertion errors were eliminated from all replicons by a mapping of
aired end Illumina HiScanSQ reads with BWA  (Li and Durbin, 2009)
nd subsequent variant calling as well as consensus correction
ithin CLC Genomics Workbench 6.5 (CLC bio, Aarhus, Denmark).
hus, a highly curated consensus sequence was extracted, which
nally was handed over to the “RS BridgeMapper.1” protocol
ithin SMRTPortal 2.1.1.
Prior to RNA-seq data analysis, the two chromosomal sequences
ere automatically annotated using the online xBASE bacterial
enome annotation service with default parameters (Chaudhuri
t al., 2008).
DNA library construction and cDNA sequencing
cDNA libraries for the early and late S. aureus isolate were
onstructed by Vertis Biotechnology AG (http://www.vertis-
iotech.com/). Brieﬂy, primary bacterial transcripts (most mRNAs
nd sRNAs) which carry a 5′ triphosphate (5′PPP) were enriched
rom total RNA samples using Terminator 5′-phosphate dependent
xonuclease (TEX, Epicentre, Madison, WI,  USA) (Sharma et al.,
010). After fragmentation of RNA by ultrasound treatment, the
NA probes were tobacco acid pyrophosphatase (TAP, Epicentre)
reated to remove 5′PPP from primary transcripts. 3′-ends of RNA
ere poly(A) tailed using poly(A) polymerase and a synthetic RNA
dapter was ligated to 5′P-ends of RNA fragments. First-strand
DNA synthesis was applied using an oligo (dT)-adapter primer
nd M-MLV  H-reverse transcriptase. The synthesized cDNAs were
CR-ampliﬁed to about 20–30 ng/l using a high ﬁdelity DNA poly-
erase and primers designed for TruSeq sequencing (Illumina
nc., San Diego CA, USA). Speciﬁc barcode sequences (ATCACG or
GATGT) were attached to the 5′ends of the cDNAs. After syn-
hesis, the cDNA was puriﬁed by the Agencourt AMPure XP kit
Beckman Coulter Genomics, Danvers, MA,  USA) and analyzed on a
himadzu MultiNA microship electrophoresis system (Shimadzu
eutschland GmbH, Duisburg, Germany). For sequencing on anedical Microbiology 305 (2015) 38–46
Illumina HiScanSQ sequencer (Illumina), cDNA libraries were
pooled using equimolar amounts of the different samples and
100 bp single reads were generated.
Read mapping and analysis of RNA sequencing data for
transcriptomic analysis
For comparative transcriptome analysis, we  used the CLCbio
Genomics Workbench software version 7.04 (CLCbio) using default
parameters. As reference sequences for mapping of the sequenc-
ing reads the chromosome of S. aureus F343795 (early isolate) was
selected (ENA study accession no PRJEB5528). Reads that mapped
on rRNA encoding genes were removed as an in-silico rRNA deple-
tion step using the READemption tool (Förstner et al., 2014) and
the resulting reads were subsequently used for the ﬁnal analysis.
After mapping of these reads on the reference genome, we  used
the raw read counts for each gene for normalization and subse-
quent determination of transcriptional changes between the two S.
aureus isolates (fold change analysis). The fold change (f) was  cal-
culated using the early isolate as a reference and the results were
stratiﬁed into differently expressed genes in the late isolate with
≥2f, ≥4f, or ≥8f and into genes that were either not expressed in
both isolates or not present on the genome level in both isolates.
For exclusion of low abundant transcripts, we used a threshold of
less than 3 reads per gene. For further analysis, we focused on sub-
sets of genes that were up- or down-regulated in the late isolate
with a ≥8f.
Quantitative real-time PCR (qRT-PCR) from RNA
To conﬁrm RNA-Seq data, differently expressed genes in the
late S. aureus isolate exhibiting ≥8f and if applicable further
related genes were selected for qRT-PCR. Primers were designed
for candidate genes and the housekeeping gene hup (DNA-binding
protein HU, locus tag F343795 1414), which was used as refer-
ence gene for normalization, as it showed comparable low fold
changes in comparison to other housekeeping genes suggested by
Derzelle et al. (2009). For primer design, the software Primer3 was
used (http://biotools.umassmed.edu/bioapps/primer3 www.cgi).
Primer sequences (Supplementary data: Table S2) were designed
based on the gene sequences of S. aureus F343795 (early isolate) and
checked for gene speciﬁcity by NCBI-BLAST search in the genome.
In a two-step qRT-PCR, total RNA was synthesized to cDNA using
the QuantiTect Reverse Transcription Kit (Qiagen). The Kit includes
a DNase digestion step to eliminate remaining genomic DNA. For
cDNA synthesis, 0.56 g of total RNA were used in a ﬁnal reac-
tion volume of 80 l following the reverse transcription procedure:
reverse transcription 42 ◦C for 15 min  and enzyme inactivation
95 ◦C for 3 min. Negative controls (without reverse transcriptase)
were checked for genomic DNA contaminations. We  used the Quan-
tiTect SYBR Green PCR Kit (Qiagen) for the second step (the dye ROX
was used for ﬂuorescence normalization) and performed the reac-
tions in a StepOnePlus real-time PCR machine (Applied Biosystems,
Foster City, CA, USA) under following cycling conditions: one ini-
tial PCR activation step at 95 ◦C for 15 min  followed by 40 cycles
of denaturation at 94 ◦C for 15 s, annealing at 53 ◦C for 30 s, and
elongation at 72 ◦C for 30 s. For speciﬁcity testing, a melting curve
analysis was  added. As template, either 0.8 l of cDNA or waterconcentration of 300 nM.  A relative quantiﬁcation (RQ) value was
calculated using default parameters of the StepOne Software ver-
sion 2.1 (Applied Biosystems) for each target gene using the early
S. aureus isolate as a reference and hup for normalization.
al of Medical Microbiology 305 (2015) 38–46 41
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Fig. 1. Comparative transcriptomic analysis of the late S. aureus isolate versus
the  early isolate. The histogram displays the number of genes with increased or
decreased transcription as fold change values of the late isolate in comparison toN. Windmüller et al. / International Journ
nalysis of genomic alterations within candidate genes and their
pstream promoter regions
To analyze candidate genes (≥8f, RNA-Seq) or operon genes
nd their intergenic upstream regions (likely promoter regions) for
enomic alterations in the late isolate, we compared the genome
equences of the early and late S. aureus isolates per NCBI nucleotide
LAST search to identify point mutations, insertions or deletions in
hese selected genomic regions.
esults
enome sequencing of early and late S. aureus isolates
Prior to RNA-Seq, we determined the genome sequences of
he early (F343795) and the late (CF74808) S. aureus isolates. To
ccomplish complete closed genome sequences, we  applied the
aciﬁc Bioscience technology and included additional Illumina
eads that ﬁnally assembled in one bacterial chromosome, which
as trimmed, circularized and adjusted to dnaA as ﬁrst gene, for
oth isolates. Herewith, a consensus accuracy of QV 60 (99.9999%)
or both chromosomes was conﬁrmed. Additionally, for the early
solate a 30 kb extra-chromosomal element, i.e. a plasmid, was
ecorded and circularized with a consensus accuracy of 100%. Auto-
ated annotation of the chromosome resulted in 2743 CDS and
9 RNAs (19 rRNAs, 59 tRNAs, and 1 miscRNA). The chromosomal
equence of the early isolate served as reference sequence for RNA-
eq data analysis; the plasmid was not used as reference sequence
ince it was missing in the late isolate. The comparison of both
equences helped to elucidate potential genomic changes in the
ifferentially regulated genes identiﬁed by RNA-Seq.
The curated whole genome sequences have been deposited at
NA (study accession nos. PRJEB5528 and PRJEB5533).
omparative transcriptomic analysis between two sequential S.
ureus isolates
To study transcriptional changes between the early and the late
. aureus isolate, which were recovered from the airways of an
ndividual CF patient 13.2 years apart, both isolates were culti-
ated using ASM and the transcriptome was characterized using
NA-Seq. In total, 15.362809 and 12.752567 cDNA reads were
sed for subsequent analysis from the early and the late isolate,
espectively. After removal of all reads that mapped on rRNAs,
.981034 reads (12.9%) of the early and 2.654981 reads (20.8%)
f the late isolate were mapped onto the reference sequence (the
hromosomal sequence of the early isolate F343795) and ﬁltered
or 2803 features (2743 CDS, 59 tRNAs, and 1 miscRNA; the 19
RNAs were excluded). After normalization, based on raw read
ounts and subsequent comparative analysis, in total 256 (10.1%) of
he 2545 genes expressed in both isolates were up-regulated (≥2f)
n the late isolate, and 161 (6.3%) genes were down-regulated (≥2f).
ne-hundred thirty-eight (4.9%) genes were excluded due to low
bundance of transcripts (less than 3 reads per gene present). We
urther stratiﬁed the fold change data using further thresholds ≥4f
nd ≥8f (Fig. 1, Tables 1 and 2, Supplementary data: Table S3). Due
o their absence of mapped cDNA reads in at least one of the two
solates, 120 genes displayed no fold change (Supplementary data:
able S3). Genes, that were up- or down-regulated in the late iso-
ate with ≥8f (Tables 1 and 2), were selected for further analysis
nd subjected to qRT-PCR analysis for validation.p-regulated genes in the late isolate with ≥8-fold change
Of the 256 up-regulated genes, 9 genes were up-regulated in
he late S. aureus isolate with ≥8f (Table 1). In all genes that werethe early isolate. In total, 2803 features were analyzed (2743 CDS, 59 tRNA and
1miscRNA), of these 2545 were expressed in both isolate with at least three reads
per gene.
chosen for qRT-PCR conﬁrmation, qRT-PCR results corroborated
with RNA-Seq data (Table 1). The genes esxA, esaA, essA, and essC
were members of the Ess pathway (ESAT-6-like secretion system),
which comprises a cluster of at least nine genes esxA, esaA, essA,
esaB, essB, essC, esaC, esxB, and esaD (Anderson et al., 2011) (Table 3,
Supplementary data: Fig. S1). We therefore also characterized the
other genes of this pathway irrespective of their fold change val-
ues (Table 3). Interestingly, with the exception of esaB, which was
present in reads of the late isolate only (Supplementary data: Table
S3), none of the other Ess pathway genes (esaC, esxB, esaE, esaF
and esaD), that can be found in S. aureus Newman (NC 009641.1)
could be detected in the genome sequences of the two isolates.
The majority of the other up-regulated genes did not belong to an
operon, but represented important virulence or immune evasion
genes (aur, sak, spa) or were coding for hypothetical proteins only
(Table 1).
Down-regulated genes in the late isolate with ≥8-fold change
Sixteen genes were down-regulated in the late S. aureus iso-
late with ≥8f (Table 2). Among these genes, three (kdpC, kdpB
and kdpA) belonged to the kdpFABC operon (Table 4, Supplemen-
tary data: Fig. S2), encoding for a potassium (K+)-transporting
ATPase (Xue et al., 2011). No fold change could be calculated
for the gene kdpF (locus tag F343795 2182a, nucleotide position
c2242,603–2242,493) since cDNA reads of kdpF were only present
in the early isolate (Supplementary data: Table S3). However, we
subsequently analyzed all four kdp genes, kdpFABC, per qRT-PCR.
The data conﬁrmed that all four genes were down-regulated in
the late isolate with comparable ratios (Tables 2 and 4). Moreover,
two genes (locus tags F343795 1914 and F343795 2110, Table 2)
encoding an amidase and the toxic shock syndrome toxin-1, dis-
playing down-regulation in the late isolate with high fold changes
in RNA-Seq data. However, as both genes were not completely
found in the genome sequence of the late isolate, we considered
the detected reads in the late isolate as unspeciﬁcally mapped reads
and excluded both genes from further analysis (Table 2).
Genomic alterations within candidate genes and their upstream
promoter regions
To determine whether changes in gene expression were due to
genomic alterations either within the respective gene or upstream
in the promoter region of the gene or operon, we used the whole
genome sequences of both isolates and analyzed the affected genes
or operons and their upstream regions (intergenic regions). Besides
the change of the spa type that became obvious already during
42 N. Windmüller et al. / International Journal of Medical Microbiology 305 (2015) 38–46
Table  1
Up-regulated genes (n = 9) in the late S. aureus isolate with ≥8f in RNA-Seq.
Locus tag (gene) Target rangea (size) Fold change Gene product qRT-PCR results (log2 RQ)
F343795 0061 (spa) c71,987–70,425 (1563 bp) 61.3 IgG-binding protein A precursor Conﬁrmed RNA-Seq (8.12)
F343795 0228 (esxA) 271,337–271,630 (294 bp) 10.1 EsxA of the Ess secretion pathway Conﬁrmed RNA-Seq (5.73)
F343795 0229 (esaA) 271,713–274,742 (3330 bp) 14.0 EsaA the Ess secretion pathway Conﬁrmed RNA-Seq (3.41)
F343795 0230 (essA) 274,742–275,200 (449 bp) 8.9 EssA the Ess secretion pathway Conﬁrmed RNA-Seq (4.25)
F343795 0233 (essC) 276,831–281,231 (4401 bp) 12.7 EssC the Ess secretion pathway Conﬁrmed RNA-Seq (4.40)
F343795 2045 (sak) c2121,492–2121,001 (492 bp) 9.9 Staphylokinase precursor Conﬁrmed RNA-Seq (2.18)
F343795 2121 2180,739–2181,106 (368 bp) 12.8 Hypothetical protein Not determined
F343795 2740 (aur) c2817,268–2815,739 (1530 bp) 11.3 Zinc metalloproteinase aureolysin Conﬁrmed RNA-Seq (2.50)
F343795 2807 c2896,825–2896,151 (675 bp) 8.7 Putative exported protein Not determined
a The preﬁx c marks the complementary orientation of the gene.
Table 2
Down-regulated genes (n = 16) in the late S. aureus isolate with ≥8f in RNA-Seq.
Locus tag (gene) Target rangea (size) Fold change Gene product qRT-PCR results (log2 RQ)
F343795 0466 504,377–504,501 (125 bp) 8.7 tRNA-Gly Not determined
F343795 0539 590,038–590,357 (320 bp) 10.5 Hypothetical protein Not determined
F343795 0540 (vraX) c590,558–590,775 (218 bp) 25.1 VraX Conﬁrmed RNA-Seq (−5.57)
F343795 1086 1152,930–1153,114 (185 bp) 9.3 Anti protein Not determined
F343795 1649 1748,685–1749,190 (506 bp) 12.5 Hypothetical protein Not determined
F343795 1914b c2009,644–2008,199 (1446 bp) 175.4 Amidase N/A
F343795 1982 (vraS) 2055,895–2056,988 (1094 bp) 9.1 Histidine kinase sensor Not determined
F343795 2110b (tst) 2172,703–2173,407 (705 bp) 457.7 Toxic shock syndrome toxin-1 N/A
F343795 2180 (kdpC) c2238,685–2238,167 (519 bp) 44.9 Potassium-transporting ATPase subunit C Conﬁrmed RNA-Seq (−4.14)
F343795 2181 (kdpB) c2240,783–2238,747 (2037 bp) 59.6 Potassium-transporting ATPase subunit B Conﬁrmed RNA-Seq (−4.32)
F343795 2182 (kdpA) c2242,445–2240,793 (1653 bp) 59.8 Potassium-transporting ATPase subunit A Conﬁrmed RNA-Seq (−5.27)
F343795 2317 2385,749–2386,224 (476 bp) 11.6 Hypothetical protein Not determined
F343795 2472 2524,542–2524,997 (456 bp) 20.5 Putative membrane protein Not determined
F343795 2544 c2602,016–2601,924 (93 bp) 21.1 Hypothetical protein Not determined
F343795 2608 2673,273–2674,063 (791 bp) 9.5 MerR family regulatory protein Conﬁrmed RNA-Seq (−2.62)
F343795 2660 2728,935–2729,135 (201 bp) 17.8 Putative exported protein Not determined
N/A, not applicable.
a
uence
l ded th
i
f
r
w
t
T
E
NThe preﬁx c marks the complementary orientation of the gene.
b These genes are either completely absent or at least partially (below a DNA seq
ate  isolate. We therefore rated these results as unspeciﬁc read mappings and exclu
nitial spa typing (deletion of a single 24 bp repeat), we found only
ew genomic alterations (Supplementary data: Table S4). In the
emaining investigated genes, the further detected point mutations
ere not located in promotor regions up to 50 bp upstream the
ranscription start site (Supplementary data: Table S4).
able 3
xpression values of the Ess pathway genes of S. aureus.
Locus tag (gene) Fold change
(up-regulated)
Gene product 
F343795-0228 (esxA) 10.1 EsxA secreted by the E
F343795-0229 (esaA) 14.0 EsaA membrane prote
F343795-0230 (essA) 8.9 EssA membrane protei
EsxB and EsaC across t
F343795-0231 (esaB) –a EsaB cytoplasmic prote
F343795-0232 (essB) –a EssB membrane protei
EsxB and EsaC across t
F343795-0233 (essC) 12.7 EssC membrane protei
EsxB and EsaC across t
esaCb or esxC N/A EsaC secreted by the E
esxBb N/A EsxB secreted by the E
esaEb N/A EsaE function unknow
esaFb or esxD N/A EsaF or EsxD secreted 
esaDb or essD N/A EsaD, membrane prote
/A, not applicable.
a Not expressed in the early isolate (F343795).
b These genes are missing in S. aureus F343795 and CF74808. similarity threshold of 90% and an overlap of <99%) missing in the genome of the
ese genes from further analysis.
Gene-expression in intermediate S. aureus isolatesA subset of the genes that were up- or down-regulated in the
late isolate (≥8f) were further analyzed in ﬁve isogenic intermedi-
ate S. aureus isolates of this patient (Supplementary data: Table S1)
Reference(s)
ss system, virulence factor Anderson et al. (2011), Burts
et al. (2005)
in Anderson et al. (2011), Burts
et al. (2005)
n, essential for the transport of EsxA,
he bacterial envelope
Anderson et al. (2011), Burts
et al. (2005)
in, negative regulator of EsaC Anderson et al. (2011), Burts
et al. (2008)
n, essential for the transport of EsxA,
he bacterial envelope
Anderson et al. (2011), Burts
et al. (2005),  Chen et al. (2012)
n, essential for the transport of EsxA,
he bacterial envelope
Anderson et al. (2011), Burts
et al. (2005)
ss system, virulence factor Anderson et al. (2011), Burts
et al. (2008)
ss system, virulence factor Anderson et al. (2011), Burts
et al. (2008, p. 200, 2005)
n Anderson et al. (2011)
by the Ess system Anderson et al. (2013),
Anderson et al. (2011)
in, required for EsxA secretion Anderson et al. (2011)
N. Windmüller et al. / International Journal of Medical Microbiology 305 (2015) 38–46 43
Fig. 2. Gene expression patterns in intermediate S. aureus isolates. Three candidate genes 
(≥8f)  and kdpE (D) were selected and investigated by qRT-PCR in ﬁve additional (interme
persistence of S. aureus in the CF airways. The early isolate was  used as a reference to calc
Table 4
Expression values of the Kdp operon of S. aureus (Xue et al., 2011).
Locus tag (gene) Fold change
(down-regulated)
Gene product
F343795 2180 (kdpC) 44.9 Potassium-transporting
ATPase subunit C
F343795 2181 (kdpB) 59.6 Potassium-transporting
ATPase subunit B
F343795 2182 (kdpA) 58.9 Potassium-transporting
ATPase subunit A
F343795 2182a (kdpF) –a Potassium-transporting
ATPase subunit F
F343795 2183 (kdpD) 2.7 Sensor kinase protein
F343795 2184 (kdpE) 3.1 Response regulator protein
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2a Gene is present with an identical sequence in both isolates but not expressed in
he  late isolate (CF74808).
sing qRT-PCR to determine gene expression patterns over the
ourse of long-term persistence using the early isolate (from 1995)
s a reference. Interestingly, we observed different patterns of gene
xpression for S. aureus during long-term adaptation in the CF air-
ays. For spa, we noticed an increase in gene expression in the
ourse of time. In the early years, 1997 and 2000, spa was  expressed
t relatively low ratios. Starting from 2002, a clear increase in gene
xpression (up-regulation) was observed, reaching its peak in 2006
Fig. 2A). The Ess pathway gene esxA was highly expressed at com-
arable gene expression ratios over the years, except for 2000 when
 low ratio was monitored (Fig. 2B). The kdp operon gene kdpC was
xpressed lowly in nearly all intermediate isolates, but shifted to
own-regulation in the late isolate in 2008 (Fig. 2C). For kdpE a sim-
lar pattern as for kdpC could be observed with very low expressions
n intermediate isolates and a trend to down-regulation in the late
solate (Fig. 2D).
ene expression of candidate genes under different pO2Since various ecological niches exist in the CF lung, such as
xygen-limited and anaerobic environments (Schobert and Tielen,
010; Tunney et al., 2008; Worlitzsch et al., 2002), we wonderedspa (A), esxA (B), kdpC (C) that were highly differentially expressed in the late isolate
diate) isolates to determine gene expression patterns over the course of long-term
ulate the relative quantiﬁcation (RQ) value for each target gene.
whether the genes that were highly expressed in the late iso-
late (≥8f) under aerobic conditions, would also show similar gene
expression patterns under microaerophilic and anaerobic condi-
tions. Analysis of the gene expression of six genes (esxA, aur,  kdpC,
kdpE, sak, and spa) in the early and late S. aureus isolate under
aerobic, microaerophilic and anaerobic conditions resulted in sim-
ilar expression tendencies in nearly all genes (the only exception
was kdpE under anaerobic conditions) under all three pO2 condi-
tions irrespective whether the genes were up- or down-regulated
(Fig. 3A–C). Whereas spa transcription rates increased in the course
of time (Fig. 2A) and in the comparative analysis under all pO2
conditions tested (Fig. 3A–C), in relation to hup alone spa is down-
regulated under oxygen-limited and even more under anaerobic
conditions (Table S5) corroborating previous ﬁndings by Pragman
et al. (2004).
Discussion
Based on RNA-Seq data that were mapped on the originating
chromosomal sequences, we were able to determine transcriptio-
nal changes between sequential S. aureus isolates during 13.2 years
of long-term persistence in a CF patient. In general, we observed
that a much higher number of genes were up- than down-regulated
in the late isolate with ≥2f. An explanation for this considerable
difference might be the selective pressure that leads to a general
activation of many genes in order to facilitate survival. For deeper
analyses, we  selected a smaller set of candidate genes that were
highly differentially expressed in the late isolate (≥8f). After vali-
dation of the RNA-Seq data using qRT-PCR, focusing on 25 genes
that were highly up- (Table 1) or down-regulated (Table 2), we
were able to identify several genes encoding for virulence factors
that have an impact on the host-pathogen interaction, e.g., by facil-
itating immune evasion during persistence in the lung.A major factor in the evasion of the host immune system,
the gene encoding staphylococcal protein A (Spa), was  highly up-
regulated in the late isolate. Spa allows for IgG by binding of Fc
fragments and enables the microorganism to evade host immune
44 N. Windmüller et al. / International Journal of M
Fig. 3. Gene expression of candidate genes under different pO2. Candidate genes
that  were highly differently expressed in the late isolate under aerobic condi-
tions (≥8f) and kdpE were selected and investigated by qRT-PCR under aerobic (A),
microaerophilic (B) and anaerobic (C) conditions mimicking aerated, oxygen-limited
a
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r
t
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s
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e
tnd non-aerated niches in the CF lung environment. The early isolate was  used as a
eference to calculate the relative quantiﬁcation (RQ) value for each target gene.
esponse to facilitate survival and establish infection. Anchored to
he cell surface, Spa binds IgG Fc fragments, blocks their recognition
y Fc receptors on neutrophils, and thereby prevents phagocyto-
is and classical pathway complement ﬁxation (Atkins et al., 2008;
oster, 2005). Whether mutations within the repeat region of spa
ight explain the increased transcription rate of spa is not known.
owever, in a previous study we have already detected genomic
hanges within spa from sequential S. aureus isolates that might
ndicate its inﬂuence on long-term persistence in CF patients (Kahl
t al., 2005). Here, we detected a new, closely related spa type for
he ﬁrst time in the isolate from 2002. Interestingly, a repeat ofedical Microbiology 305 (2015) 38–46
the variable region was  deleted during persistence, which is in line
with the observation of Garofalo et al. (2012), who described that
during chronic osteomyelitis the number of spa repeats decreased
in S. aureus isolates and that such mutations were associated with
a reduced inﬂammatory response.
Two other genes encoding for staphylokinase (SAK, locus tag
F343795 2045) and aureolysin (locus tag F343795 2740) were also
among the ≥8f up-regulated genes. Interestingly, both gene prod-
ucts have similar functions as they facilitate the bacterial spread
in the extracellular matrix via activation of the ﬁbrinolysis and
degradation of extracellular matrix proteins (Beaufort et al., 2008;
Bokarewa et al., 2006; Braff et al., 2007; Parry et al., 2000; Stephens
and Vaheri, 1993). Moreover, SAK and aureolysin are involved in
the evasion of the host immune system by interacting via different
mechanisms of the innate and adaptive immune system (Jin et al.,
2004; Prokesˇová et al., 1991; Rooijakkers et al., 2005). Degrada-
tion of antimicrobial peptides like cathelicidin (Sieprawska-Lupa
et al., 2004), which is produced by alveolar macrophages and air-
way epithelial cells at the sites of infection (Agerberth et al., 1999;
Bals and Hiemstra, 2004), and of different components of the com-
plement system (Laarman et al., 2011; Rooijakkers et al., 2005)
by proteases is a common strategy to escape host complement
responses that has also been demonstrated in other gram-positive
bacteria like Group A streptococci (Nizet, 2007). We therefore
assume that the detected up-regulation of staphylokinase and aure-
olysin fosters the survival of S. aureus during long-term persistence
in the CF-lung.
Besides single genes, we  also found several genes of a pathway
up-regulated: four genes of the Ess pathway (esxA, esaA, essA, essC)
were up-regulated in the late isolate. The pathway was initially
described in M. tuberculosis as a secretion system for two virulence
factors (ESAT-6 and CFP-10) (Berthet et al., 1998; Guinn et al., 2004;
Sørensen et al., 1995; Stanley et al., 2003), but later homologues of
ESAT-6 have also been identiﬁed in S. aureus (Pallen, 2002). The
exact function of this pathway in pathogenicity is still unclear.
In our analysis we  found only four genes of this pathway. The
remaining genes, namely esaC, esxB, esaE, esaF, and esaD, were miss-
ing in the genome sequences of the early and late isolate. Via BLAST,
we searched for Ess genes in the 33 complete S. aureus genomes that
were available in the NCBI database at the time of this investiga-
tion (25th January, 2013) using the Ess genes of the Newman strain
(NC 009641.1: NWMN  0219–NWMN 0228). Similar to our isolates,
the same Ess genes (esaC, esxB, esaE, esaF and esaD) were missing
in twelve of the 33 published genomes (strains MRSA252, MN8,
M013, TW20, ST398, LGA251, JKD6008, TCH60, T0131, 71193, HO
5096 0412 and 08BA02176). Anderson et al. (2011), reported a bursa
aurealis insertion in esaD in S. aureus strain USA300 that resulted in
a reduced secretion of EsxA. However, these missing genes might
not be crucial for the pathway function. The remaining proteins of
the Ess pathway genes, which are up-regulated in the late isolate,
might be sufﬁcient for the transport of EsxA and perhaps for further
so far unidentiﬁed proteins.
Among the down-regulated genes, the four genes of the kdp
operon (kdpFABC) warrant further attention. Whereas the operon
was primarily described as a high-afﬁnity K+ transporter in several
bacteria (Bakker et al., 1987; Garcia-Cuellar et al., 1995; Polarek
et al., 1992; Treuner-Lange et al., 1997), it has been shown that in
S. aureus the transcription of kdpFABC is not activated under low
external K+ concentrations by KdpDE, suggesting another function
in S. aureus (Xue et al., 2011). Indeed, Xue et al. (2011) showed
that the transcription of several virulence genes, such as spa, cap,
hla,  aur,  geh, and hlgB, were altered in a kdpDE S. aureus mutant,
and that KdpE can speciﬁcally bind to the promotor regions of the
genes, except hla, in vitro (Xue et al., 2011). However, Xue et al.
also found out that a speciﬁc binding of KdpE to kdpDE did not
inﬂuence their transcription; therefore, we cannot infer from our
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ranscriptional data alone the KdpE activity. We  additionally found
wo synonymous point mutations in kdpB and kdpE and an insertion
f an adenine (A) in kdpD (Supplementary data: Table S4); how-
ver, as the expression patterns in the intermediate isolates were
lso different to the patterns of spa, we refuted the hypothesis of a
inked transcription.
One limitation in our study might be the fact that we used aer-
bic conditions as a starting point for our analysis though many
reas of the CF lung are only poorly aerated. As the character-
zed genes showed similar expression tendencies under all three
O2 conditions (aerobic, microaerophilic, anaerobic) irrespective
hether they were up- or down-regulated (Fig. 3), we  concluded
hat variation in the pO2 was not the trigger for the initially detected
ranscriptional changes between the early and the late isolate under
erobic conditions. Due to our starting point “aerobic conditions”,
owever, all genes that might be highly up- or down-regulated
nder microaerophilic or anaerobic conditions are excluded. More-
ver, in our approach we might have lost additional candidate
enes if they were not expressed in both isolates. As it became
bvious in the meantime that sequencing with a lower depth and
erforming more biological replication should be preferred over
ncreased sequencing depth (Rapaport et al., 2013), we  see another
otential limitation of our analysis as we used only one biologi-
al replicate for RNA-Seq with high sequencing depth. However,
s we employed qRT-PCR for conﬁrmation of RNA-Seq results, we
elieve that this technical limitation did not considerably bias our
nalysis.
In summary, our transcriptome data demonstrated that exces-
ive transcriptional changes occur in S. aureus isolates during
ong-term adaptation and that several genes are highly up-
egulated in the late S. aureus isolate after 13.2 years of persistence
n the CF lung. These genes encode proteins that play a role in
mmune evasion, inhibit the host adaptive and innate immune
ystem or inactivate bactericidal peptides. Since SAK and aure-
lysin are also able to manipulate and activate the host ﬁbrinolytic
ystem, bacterial spread might also be an important mechanism
nabling the bacteria to colonize new niches in the CF lung. Ana-
yzing the gene expression in intermediate isolates, we detected
 clear up-regulation of spa in the last six years of persistence
hat might illustrate the signiﬁcance of this protein for S. aureus
specially during later years of persistence in the CF airways. In
ontrast, we also observed different patterns of gene expression
or the other tested genes over the years, which might reﬂect on
he pathogen’s side either localized effects or effects of different
. aureus regulatory systems on the gene expression. Regarding
he host’s side, changes in the CF lung micro-environment that
ccurred prior to the isolation of our isolates might have con-
ributed to the adaptive changes. Therefore, future studies will not
nly focus on the host side to elucidate factors that might have
n impact on the establishment of transcriptional changes dur-
ng long-term adaptation thereby contributing to the adaptation
f S. aureus in the CF airways, but also try to determine simultane-
usly the transcription rate of the pathogen and the host using dual
NA-Seq (Westermann et al., 2012), ideally directly from in vivo
amples.
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